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The haemoglobinopathies – thalassaemias and abnor-
mal haemoglobins – constitute a major burden of genetic 
diseases in India. Our study, based on index cases 
from 120 families detected between May 1999 and May 
2003, highlights the ethnic distribution of haemoglo-
binopathies in regions in and around Varanasi com-
prising 8–10 districts of eastern Uttar Pradesh and 
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adjoining districts of Bihar, Jharkhand, Chhattisgarh 
and Madhya Pradesh. Homozygous and heterozygous 
b-thalassaemia was the most common (66.9%), with 
thalassaemic haemoglobinopathies HbE-b-thalassaemia 
(15.9%) and HbS-b-thalasseamia (7.8%) contribut ng 
to almost a quarter of the cases. Along with HbSS dis-
ease (4.3%), the results indicate a confluence of b-tha-
lassaemia, HbS and HbE in this region. IVS1-5 nt was 
the most common mutation in the few carriers analysed 
for mutation detection. The significance of the study lies
in the demonstration of wide prevalence of b-thala-
ssaemia across all castes and communities of this re-
gion, with migrant population groups of Sindhis and 
Punjabis comprising only 5.8% of the index cases. 
Also, HbE seems to have a much higher presence in 
this region than so far believed and HbS has a signifi-
cant presence in general castes as well. 
 
THE inherited disorders of haemoglobin – thalassaemias 
and haemoglobinopathies – constitute a major burden of 
genetic disorders in India. Reports from different parts of 
the country have enabled mapping of ethnic distribution 
and prevalence of thalassaemias and the three common 
symptomatic abnormal haemoglobins S, D and E1–3. I  
the studies from north India, major groups of thalassae-
mics from Uttar Pradesh are the migrant ethnic popula-
tions of Punjab and Sindh origin4–7. The presence of HbE in 
Uttar Pradesh (UP) has been detected by way of sympto-
matic cases of HbE b-thalassaemia. In the cases recorded 
between 1987 and 1995, Agarwal et al.8 reported 21 fami-
lies with HbE-b-thalassaemia. Sporadic cases have been 
mentioned in a few other reports9–11. According to Balgir2, 
the average frequency of HbS gene in UP is around 7.2%, 
mostly in tribal and scheduled caste populations, but per-
meating into general castes as well. Nearly 28 mutations 
in b-globin gene have so far been recorded in the Indian 
subcontinent, among which five (IVS1-5 (G ® C), –619 bp 
del, IVS1-1 (G ® T), CD8/9 (+ G), CD41/42 (-CTTT)) ac-
count for more than 90% of the cases4. 
 Eastern UP and adjoining regions of Bihar, Madhya 
Pradesh (MP), Chhattisgarh and Jharkhand are poorly 
represented in the studies from northern India. Varanasi 
serves as a medical referral centre for this region. In this 
study, data based on 120 index cases from unrelated 
families detected over a period of four years from May 
1999 to May 2003, at the only referral laboratory for tha-
lassaemia in Varanasi, are presented. The present study 
documents considerable presence of thalassaemias, haemo-
globinopathies and thalassaemic haemoglobinopathies in 
the native populations of these regions, largely independ-
ent of caste. 
 All the index cases reported here came from unrelated 
families residing in this region. These cases were referred 
to our laboratory from the hospital in Banaras Hindu 
University (BHU) and other private clinics between May 
1999 and May 2003. The partial map of India (Figure 1) 
illustrates the geographical regions from where the cases 
were referred. Two cases, initially detected elsewhere and 
reported to our laboratory for follow-up, have also been 
included here. Mutational analysis was carried out in the 
Cytogenetics Laboratory, Department of Zoology, BHU. 
 Diagnosis of each case was based on haematological 
investigations which included complete blood counts on 
semiautomated blood cell counter (Danam HC 5710), peri-
pheral smear examination, reticulocyte count and HbH 
inclusions. Electrophoresis on cellulose acetate at pH 8.6 
allowed resolution of different haemoglobins12. HbA2 and 
HbE were estimated by microcolumn chromatography us-
ing glycine–cyanide developers, and foetal haemoglobin 
was estimated by alkali denaturation method of Singer12. 
Wherever required, these tests were supplemented by r -
cell osmotic fragility, serum bilirubin and liver function 
tests, serum iron and iron-b nding capacity and sickling test12. 
Diagnosis of HbE-b-thalassaemia and HbS-b-thalassaemia 
in all index cases has been confirmed by simultaneous 
studies in parents, where one parent had b-thalassaemia  
 
 
 
 
Figure 1. Partial map of India depicting regions of eastern Uttar 
Pradesh and adjacent States from where samples have been referred. 
The map of India below indicates the location of th s region in the na-
tional context. Symbols indicate different haemoglobinopathies repre-
sented proportionately. 
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trait and HbE or HbS trait in the other. The thalassaemic 
phenotype has been broadly classified into thalassaemia 
major, intermedia and minor based on stand rd criteria 
mentioned13,14. 
 For detection of mutation, genomic DNA of suspected 
carriers, extracted from a small sample of peripheral blood, 
was PCR-amplified using the standard ARMS strategy  
of common mutation detection in b-globin and HbE  
(viz. IVS1-1nt G-T, IVS1-5 nt G–C, CD 8/9 + G, CD 41/42  
(-TCTT), HbE CD 26 G–A; standard primers obtained from 
Genei, India). The PCR conditions were as recommended. 
DNA (100 ng) was subjected to 30 cycles of denaturatio , 
annealing and extension at 94, 58 and 72°C respectively. 
The reaction was carried out in a programmable thermal 
cycler (Genius, TECHNE, UK). 
 Out of 120 cases, 80 (67%) were of b-thalassaemia 
(b/b = 59; b/A = 21), 19 (15.9%) of HbE-b-thalassaemia, 
and 9 (7.8%) of HbS- -thalassaemia, all belonging to  
Varanasi and surrounding regions of eastern UP, neigh-
bouring districts of Bihar, Jharkhand, MP and Chhattisgarh. 
In addition, there were five cases of homozygous sickle 
cell disease, two of HbH disease and two each of HbD 
trait and HbS trait. Single case of HbE trait was also de-
tected. Regional distribution is depicted in Figure 1. 
 Distribution of different haemoglobinopathies presntly 
examined is given in Table 1. Patients with thalassaemic 
phenotype have been broadly classified into thalassaemia 
major (transfusion-dependent disease), intermedia (largely
transfusion-i dependent growth with transfusional sup-
port required during intercurrent illnesses/crises leading 
to sudden drop in Hb levels) and minor, i.e. asymptomatic 
cases. Among the 80 cases of b-thalassaemia, 59 (49%) 
were of homozygous b-thalassaemia (45 presented as ha-
lassaemia major and 14 as thalassaemia intermedia), 21 
(17%) of heterozygous b-thalassaemia (MCV < 80 fl, 
normal serum iron, HbA2 > 3.5%, HbF < 5%), of which 
two were asymptomatic (thalassaemia minor) and 19 were 
assigned to thalassaemia intermedia phenotype. All but 
one of these 19 cases presented to us in adulthood with 
igns and symptoms severe enough to require medical 
support and pertaining to chronic refractory haemolytic 
anaemia. The clinico-haematologic data of these cases are 
presented in Table 2. There were 19 cases of HbE-b-tha-
lassa mia and 9 (23.3%) of HbS-b-thalassaemia. Among 
the HbE-b cases, the thalassaemia major and intermedia 
phenotypes were almost in equal proportions, 9 and 10 
respectively. Five of these thalassaemia intermedia cases 
were presented to us between 12 and 32 years of age with 
moderate to massive splenomegaly, chronic anaemia with 
Hb levels ranging from 4.2 to 6.4 g/dl, mild icterus and 
mild haemolytic facies. The remaining four, presented bet-
ween 4 and 5 years of age, were transfusion-independent 
with mild to moderate splenomegaly. One case was diag-
nosed at 2 years of age. The HbS-b-thalassaemia patients 
had more severe disease with lower Hb levels and sys-
temic involvement than their counterparts having homo-
zygous sickle cell disease (HbSS; five cases). 
Broad ethnic classification of the cases (Table 3) revea-
led that more than 80% cases were native Hindus of this 
region; 50% belonging to Brahmin, Thakur, Bania, Mar-
wari and Kayasth communities, and 34.1% were mostly 
Yadavas, Kurmis, Kharwars, Vishwakarmas nd sched-
uled castes. Punjabis and Sindhis contributed only 5.8% 
of the cases. Thirteen (10.8%) cases were from Muslim fami-
lies a ong which ten were of homozygous-b-thala saemia, 
two of HbE-b-thalassaemia and one of HbSS disease (from 
Bihar). Some cases as igned to ‘unknown’ group, were all 
Hindus but their specific caste was not known. 
 All but one of the five homozygous sickle cell disease 
(HbSS) index cases belonged to scheduled castes and tribes. 
The lone Brahmin family belonged to Sonebhadra region. 
However, of the nine index cases of HbS-b-thalassaemia, 
five were Kshatriya and Brahmin. Only two cases of HbD 
were detected of which one was accidentally detected in 
an asymptomatic 32-year-old Punjabi male. The other was 
a four-year-old Sindhi anaemic boy, whose mother was a 
carrier for HbD trait. However, his father did not show 
any abnormal haemoglobin or b-thalassaemia trait by the 
 
 
Table 1. Haemoglobinopathies in Varanasi region and their clinical phenotypes 
 Thalassaemia Thalassaemia Thalassaemia Sickle cell 
Clinical phenotype  major intermedia minor disease Asymptomatic Total 
 
Haemoglobinopathies n % n % n % n % n % n % 
 b/b-thalassaemia 45 81.8 14 30.4 –  –  –   59 49.1 
 b/A-thalasseamia –  19 41.3 2 100 –  –   21 17.5 
 HbE-b-thalassaemia  9 16.4 10 21.7 –  –  –   19 15.9 
 HbE trait    1 2.2 –  –  –    1  0.8 
 HbS/S disease –  –  –   5 35.7 –    5  4.3 
 HbS-b-thalassaemia        9 64.3     9  7.8 
 HbS trait   –  –  –  2 50.0   2  1.7 
 HbH disease    2 4.3 –  –  –    2  1.7 
 HbD trait     –  –  2 50.0   2  1.7 
 Total 55 45.8 46 38.4 2 1.7 14 11.6  4 3.3 120 100 
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Table 2. Clinico-haematologic data of heterozygous b-thalassaemia cases – thalassaemia intermedia 
 Hb MCV/MCH/ RBC Hb 
Age/sex  (g/dl) RDW morphology electrophoresis HbA2/HbF Important clinical features 
 
25 yr/F 6.7 69.0/22.5/15.9 Microcytic A + A2 4.1 0.0 Aggravation of anaemia during second trimester
     hypochromic     of pregnancy – maintained on transfusion till  
         delivery. 
48 yr/M 7.9 58.6/20.5/16.4 Anisocy++, A + A2 6.6 1.3 Persistent weakness and intermittent icterus 
   `   micr++     aggravating during intercurrent illness. 
     hypo++++     Mild hepatosplenomegaly. 
32 yr/M 7.6 62.3/22.5/21.0. Thalassaemic A + F + A2 6.7 1.5y Persistent weakness and imtermittent jaundice  
         aggravating after intercurrent illness. Spleen  
         palable. 
12 yr/F 7.4 – Thalassaemic A + A2 5.4 0.8 Persistent weakness. 
26 yr/F 6.4 – Thalassaemic A + F + A2 6.1 3.2 Severe refractory anaemia during 24–28 weeks of  
         pregnancy – maintained on regular transfusion 
         till delivery. 
25 yr/F 8.4 63.2/21.9/16.0 Microcytic A + A2  4.8 0.0 Mild weakness aggravating after illness. 
     hypochromic 
13 month/M 8.1 65.3/21.8/16.0 Microcytic A + A2 6.2 0.8 Pt presented with refractory moderate anaemia  
     hypochromic     and mild splenomegaly. 
22 yr/M 6.4 – Thalassaemic A + F + A2 4.6 2.0 Intermittent jaundice and weakness aggravating 
         during intercurrent ill ess. 
25 yr/M 7.7 64.4/22.5/20.9  Thalassaemic A + A2 4.3 1.7 Intermittent jaundice and weakness aggravating 
         during intercurrent illness. Palpable spleen. 
40 yr/F 7.7 66.1/24.2/15.4 Microcytic A + A2 3.5 0.0 Persistent weakness aggravating after mild  
     hypochromic     intercurrent illness. 
25 yr/M 7.1 61.4/19.6/15.2 Thalassaemic A + F + A2 5.0 2.0 Intermittent jaundice and weakness aggravating 
         during intercurrent illness. Liver 2.0 cm, 
         spleen 2.5 cm. 
15 yr/M 10.2 59.5/20.8/15.7 Microcytic A + A2 4.1 0.0 Weakness, mild intermittent jaundice, absence of  
     hypochromic     secondary sexual characteristics 
16 yr/M 5.8 64.1/22.3/18.1 Thalassaemic A + A2 5.8 0.0 Intermittent jaundice and weakness ggravating 
         during intercurrent illness. Spleen 2.0 cm. 
15 yr/F 7.3 69.9/24.5/18.0 Thalassaemic A + A2 4.0 0.0 Increased weakness after mild fever/illness. 
30 yr/M 6.1 62.1/21.1/18.5 Thalassaemic A + F + A2 3.6 6.2 Intermittent jaundice and weakness aggravating 
         during intercurrent illness. Spleen+. 
45 yr/M 5.0 – Thalassaemic A + A2 4.3 0.9 Presented with breathlessness and weakness 
31 yr/M 6.5 58.7/22.1/15.9 Thalassaemic A + A2 5.2 0.9 Intermittent jaundice and weakness aggravating  
         during intercurrent illness. 
18 yr/M 10.0 59.5/19.9/16.7 Thalassaemic A + F + A2 6.3 2.6 Intermittent jaundice and weakness aggravating  
         during intercurrent illness. Mild 
         hepatosplenomegaly. 
45 yr/F 9.2 57.6/20.7/16.9 Microcytic A + A2 7.3 0.0 Persistent weakness with aggravation 
     hypochromic     during fever. 
 
 
 
above mentioned methods. Further investigations could 
not be carried out due to lack of cooperation from the family. 
Also, there were two cases of a-thalassaemia, HbH dis-
ease diagnosed on the basis of microcytic hypochromic 
blood counts, normal HbA2 and serum iron and presence 
of HbH inclusions, both from lower caste Hindu families, 
one each from UP and Bihar. 
 ARMS PCR was performed on 31 individuals to assess 
the frequency of different common mutations in this region. 
Six samples came from two families (proband and both 
pa ents). In the two families, one proband was homozy-
gous for IVS1- , while the other was a compound hetero-
zygote for IVS1- /5. Both these families were of Sindhi 
origin. Rest of the 25 samples were from carrier parents 
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Table 3. Ethnic distribution of haemoglobinopathies in Varanasi region 
 Brahmins, Yadavas, Kharwars, 
Religion/caste/ Kshatriyas, Banias Mauryas, Kurmis 
ethnic group  and Kayasths and SC/STs Muslims Punjabis Sindhis Unknown Total 
 
Haemoglobinopathies n % n % n % n % n % n % n % 
 b-thalassaemia 39 75.0 23 56.1 10 76.9 2 66.7 3 75 3 42.9  80 66.9 
  (b/b and b/A) 
 HbE-b-thalassaemia  6 11.4  8 19.5  2 15.4 0 – 0 – 3 42.9  19 15.9 
 HbE trait  1  1.9  0 –  0 – 0 – 0 – 0 –   1  0.8 
 HbS/S disease  1  1.9  3 7.3  1  0.8 0 – 0 – – –   5  4.3 
 HbS-b-thalassaemia  4  7.7  4 9.8  0 – 0 – 0 – 1 14.3   9  7.8 
 HbS trait  1  1.9  1 2.5  0 – 0 – 0 – 0 –   2  1.7 
 HbH disease  0 –  2 4.9  0 – 0 – 0 – 0 –   2  1.7 
 HbD trait  0 –  0 –  0 – 1 33.3 1 25 0 –   2  1.7 
 Total 52 43.3 41 34.1 13 10.8 3  2.5 4 3.3 7 5.8 120 100 
 
 
 
or a kin of the proband. Five samples did not yield results. 
In the rest, the distribution of different alleles was as fol-
lows: IVS1 nt 5–15, IVS1 nt 1–3, CD 8/9 + G-1 and CD 
41/42 +G-1. 
 In north India, the incidence of b-thalassaemia has been 
mainly attributed to its high prevalence in the migrant 
populations of Sindhi and Punjabi origin4,5,7,8,15. HbE, the 
abnormal haemoglobin, shows high incidence in North-
eastern States and West Bengal, with a few cases in UP 
and Bihar2,8–11. HbS is reported to be prevalent among 
tribal and lower castes in MP. Thus different haemoglo-
binopathies have varied distributions in different geog a-
phical regions and ethnic groups. However, there are 
hardly any reports on their distribution in eastern UP and 
Bihar. The present study of 120 cases from unrelated 
families was carried out to unravel the ethnic diversity of 
thalassaemias and abnormal haemoglobins in these regions. 
Unlike previous reports, only five of our 80 b-thalas-
saemia cases, belonged to Punjabi and Sindhi families. In 
contrast, 72 (more than 80%) were native Hindus and 
Muslims, demonstrating that b-thalassaemia is no longer 
confined to specific ethnic groups; instead it is widely 
distributed in all castes and communities nativ  to this 
region (Table 3). Similarly, occurrence of 16.7% cases of 
HbE in the present group of samples, when viewed together 
with the reports of Agarwal et l.8 and Dube t al.9, sug-
gests the spread of HbE well beyond West Bengal through 
Bihar to eastern UP. Also, distribution of HbE-b-thalas-
seamia in all castes and communities indicates a much 
wider prevalence of HbE than hitherto assumed. 
 The other abnormal haemoglobin, HbS, which is repor-
ted to be prevalent in tribal backgrounds of MP, was also 
found in general castes of Hindus (5/9 cases of HbS-b-
thalassaemia). All of them belonged to Mirzapur–Sone-
bhadra region of UP, which is contiguous with the high 
HbS tribal regions of MP. 
 The simultaneous presence of b-thalassaemia, HbE and 
HbS in this region appears to contribute significantly to 
the load of haemoglobinopathies in these populations. 
Since many of these patients live up to adultho d with active 
reproductive life, they increase the chance of propagation 
of both b-thalassaemia and abnormal haemoglobin genes. 
It is not unreasonable to assume that fewer reports of HbE-
b-thalassaemia from this region could be because of under-
diagnosis due to low index of suspicion, prevailing ethnic 
bias, and absence of diagnostic facilities. Krishnamurthy16 
has also suspected the same for the Northeastern popula-
tio s. 
 Though a large number of b-thalassaemia-c using muta-
tions are recorded in b-globin gene, interestingly, only a 
few se m to occur in any population. In India, five com-
mon mutations (IVS1-1, IVS1-5, –619 bp del, CD 8/9 +G, 
CD 41/42 (-CTTT)) account for more than 90% of tha-
lassaemia carriers4. Among these, CD 8/9, IVS1-5 and  
–619 bp del occur in around 80% of the cases. However, 
in the two major studies comprising patients from UP and 
Bihar4,5 IVS1-5 was the most common mutation, account-
ing for more than 50% of the cases followed by CD 41/42 
(-TCTT) while three other mutations had low frequen-
cies. Similar results were obtained in an earlier study on 
cases from Kolkata17. Curiously, the uncharacterized mu-
t tions in all these studies mostly belonged to UP anBi-
har. Mutation IVS1-  has largely been detected in the 
migrant Sindhi population. In the present study on a small 
sample, the majority of carriers are IVS1-5. Six IVS1-1 
alleles were characterized in two patients from Sindhi 
fa ilies and their parents. The two cases of IVS1-1 recor-
ded happen to be parents of a b-thalassaemic child. How-
ever, they remain ethnically uncharacterized. Thus, while 
IVS1-5 is the common mutation even in these popula-
tions, a larger sample is required to be studied to have an 
estimate of the frequency of other mutations. 
 As most of the subjects in our study were symptomatic 
cases referred for investigation of refractory anaemia, the 
results only reflect the significant presence of b-thalassae-
mia and abnormal haemoglobins E and S in this region 
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across all castes and communities. Screening of healthy 
population is required to determine the carrier rates and 
gene frequencies in this region. 
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